This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Brainstorm Cell Therapeutics Ltd.. Active years: 2018-2025.
Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Yael Gothelf
Introduction
Yael Gothelf is a prominent inventor based in Kiryat-Ono, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods using exosomes. With a total of 3 patents to his name, Gothelf's work is paving the way for advancements in treating neurodegenerative diseases.
Latest Patents
One of Gothelf's latest patents is titled "MSC-NTF specific exosomes and use thereof." This patent provides highly-characterized isolated exosomes, methods to produce such exosomes, and methods for their use in treating diseases, including neurodegenerative conditions. Another notable patent is focused on "Populations of mesenchymal stem cells that secrete neurotrophic factors." This patent discloses a method for qualifying whether a cell population is a suitable therapeutic option.
Career Highlights
Yael Gothelf is associated with Brainstorm Cell Therapeutics Ltd., a company dedicated to developing innovative therapies for neurodegenerative diseases. His work at the company has been instrumental in advancing research and applications in this critical area of medicine.
Collaborations
Gothelf collaborates with several talented individuals in his field, including Yosef Levy and Revital Aricha, who contribute to the innovative projects at Brainstorm Cell Therapeutics Ltd.
Conclusion
Yael Gothelf's contributions to biotechnology and his innovative patents are making a significant impact in the treatment of neurodegenerative diseases. His work exemplifies the importance of research and collaboration in advancing medical science.